Skip to content
ppharmaranks
Menu
Class IIOngoing

Taoscare Motion Sickness Patches 36-count box recall

FDA recall D-0098-2026 · initiated Oct 9, 2025

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated Oct 29, 2025How we research

ibspot recalled Taoscare Motion Sickness Patches 36-count box in Oct 2025 — an FDA Class II recall (D-0098-2026) because Marketed Without an Approved NDA/ANDA.

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

Marketed Without an Approved NDA/ANDA

Sold unapproved, or found to contain something undeclared

The product should not have been on sale in this form — often a supplement found to contain a hidden prescription drug.

This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.

Is your product affected? Check the lot number

A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.

none

Quantity recalled: 3 boxes

Details

Product
Taoscare Motion Sickness Patches 36-count box, Henan Xinyongtal Medical Technology., Ltd., Address: he nan sheng zhou kou shi huai yang xian gong ye yuan qu, X003SR097N
Recalling company
ibspot
Classification
Class II
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
WY and VA
Initiated
Oct 9, 2025
FDA report date
Oct 29, 2025
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Frequently asked

Was Taoscare Motion Sickness Patches 36-count box recalled?
ibspot recalled Taoscare Motion Sickness Patches 36-count box in Oct 2025 — an FDA Class II recall (D-0098-2026) because Marketed Without an Approved NDA/ANDA. May cause temporary or medically reversible harm; low probability of serious harm.
Why was Taoscare Motion Sickness Patches 36-count box recalled?
Per the FDA enforcement record, the reason for recall D-0098-2026 was: Marketed Without an Approved NDA/ANDA
Is a recalled Taoscare Motion Sickness Patches 36-count box dangerous to take?
An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
Which lots of Taoscare Motion Sickness Patches 36-count box are affected?
Distributed: WY and VA. The recall covers these lots — none. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0098-2026.

Source: openFDA Drug Enforcement record D-0098-2026

← All drug recalls